The use of medical robotic technology enhances surgical results, shortens hospital stays, and lessens patient trauma. The market for medical robotic systems is also anticipated to increase favorably due to rising demand for minimally invasive treatments and procedures. In addition, fragile tissue surrounds the targeted cells in neurology, making it difficult for a surgeon to perform the procedure precisely without endangering nearby healthy tissues. So, using the acquired medical images as a guide, robotic systems are used to make precise and exact actions. In radiosurgery, focused ionizing radiation beams are aimed at the patient in order to treat tumors, and these robotic devices are also used in this procedure. People with impairments can have autonomy with the help of rehabilitation robotic devices. As a result, it is anticipated that the market for medical robotic systems will rise as a result of rising demand for such systems. The market for medical robotic systems is anticipated to increase quickly once a number of other robotic systems now in development are FDA-approved.
According to Coherent Market Insights, According to estimates, the global market for Medical Robotic Systems was worth US$ 9,099.84 million in 2019. From 2019 to 2027, the market is projected to grow at a CAGR of 14.3%.
Leading Companies in the Medical Robotic System Industry:
1. Intuitive Surgical
The company was started in 1995 and is based in Sunnyvale, California, United States. The business creates, produces, and sells robotic products aimed at enhancing patients' therapeutic outcomes. The company Intuitive Surgical, Inc. designs, produces, and sells surgical systems. Rebotix v. Intuitive is anticipated to go to trial by August 2022 after Intuitive's motion for dismissal was granted.
2. Transenterix
The company was founded in 2006 and is based in Durham, North Carolina, United States. TransEnterix, Inc. creates goods for the surgical care market. The business creates, develops, tests, and produces medical equipment for catheter-based procedures and laparoscopic surgery. Performance-Guided Surgery is a new category of surgery that TransEnterix announced in February 2021 as well as a name change to Asensus Surgical.
